Bullish Case: Q3 beat ($3.28 EPS), record $53.2B backlog, and raised FY26 guidance land against a washed-out price that has already recovered +10.2% off September lows. Catalysts stack: $500M VAMPIRE order, $60M XRC phase-2, Meadowlands CCS buy of 32-56 units, GMLRS motor capacity doubling, LISA telescope award, and Hegseth's $350B defense push. Helium's density peaks at $260 (0.0713), matching spot, with longer-tenor IV near 27-30% — event risk decays toward mean reversion higher.

Bearish Case: The term structure is sharply backwardated (market front IV 71.4% vs ~30% for May 2027), and puts traded 34% more volume than calls — hedgers still pay up for imminent downside. Momentum since June has been a serial failed rally (-8.4% YoY); Helium's AI forecast (+0.4%) carries a 0.1 realized correlation, i.e., no edge. If post-earnings IV crush meets absorption, the $255 retest reopens $245-250.

Potential Outcomes:

1. 32% — IV-crush chop $255-265: post-event front IV decays from ~71% toward Helium's 22-23% Nov prints without a spot breakout (falsifiable: 10/31 market IV halves while spot holds $255+).
2. 30% — Rebound $265-275: backlog/award headlines (VAMPIRE, XRC, Meadowlands) sustain call-side flows (falsifiable: 11/20 260C IV holds ≤32% with spot above $262).
3. 20% — Pullback $245-255: profit-taking re-inflates put skew (falsifiable: 11/20 250P IV rises above 36% while spot loses $255).
4. 12% — Rally >$275: sector rotation into defense on budget reconciliation progress (falsifiable: 02/19/27 280C delta climbs above 0.40).
5. 6% — Shock <$240: cyber incident, program cancellation, or governance contagion (falsifiable: deep-OTM 2028 put volume surges).

October 29, 2026